might return to the levels you experienced before taking semaglutide. This may lead to increased food intake and weight gain. After all, obesity is considered a chronic disease, so semaglutide can ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

Obese adults who took the weekly injection lost up to 22% of their starting weight after 11 months — compared to just 14% over 15 months for semaglutide, the active ingredient in Ozempic and Wegovy.

After 17 months on the medication ... to minimize muscle loss. Before taking semaglutide, Dunham used to tell herself she couldn't have any festive treats and then feel guilty if she did.

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight. At the Cardiometabolic Health Congress ...

Medications like semaglutide and tirzepatide have gained significant attention for their impressive weight-loss effects, but they do much more than just helping you shed pounds. Let’s dive into ...